Vivos Therapeutics, Inc. Cash and Cash Equivalents
Vivos Therapeutics, Inc. (VVOS) had Cash and Cash Equivalents of $1.77 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.77M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.11M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $2.03M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $3.09M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $1.77M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.11M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $2.03M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $4.40M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $2.34M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $6.26M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $6.31M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.90M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.61M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.64M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $988.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.94M 10-Q · filed 2023-08-16 | |
| 2023-03-31 | $7.05M 10-Q · filed 2023-06-08 | |
| 2022-12-31 | $3.52M 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | $6.72M 10-Q · filed 2022-12-20 | |
| 2022-06-30 | $12.66M 10-Q · filed 2022-12-20 | |
| 2022-03-31 | $17.83M 10-Q/A · filed 2022-11-25 | |
| 2021-12-31 | $24.03M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $28.53M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $34.20M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $14.06M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $18.21M 10-K · filed 2022-03-31 | $18.21M 10-K · filed 2021-03-25 |
| 2019-12-31 | $469.35K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |